Search Results - "Palamidas, F."

Dyspnea and respiratory muscle strength in end-stage liver disease by Kaltsakas, Georgios, Antoniou, Efstathios, Palamidas, Anastasios F, Gennimata, Sofia-Antiopi, Paraskeva, Panorea, Smyrnis, Anastasios, Koutsoukou, Antonia, Milic-Emili, Joseph, Koulouris, Nickolaos G

“…AIM:To investigate the prevalence of chronic dyspnea and its relationship to respiratory muscle function in end-stage liver disease.METHODS:Sixty-eight…”
Get full text

Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients by Gennimata, Sofia-Antiopi, Palamidas, Anastasios F., Kaltsakas, Georgios, Koulouris, Nickolaos G.

“…Patients with severe COPD often exhale along the same flow-volume curve during quite breathing as during forced expiratory vital capacity manoeuvre, and this…”
Get full text

Driving-Related Neuropsychological Performance in Stable COPD Patients by Papageorgiou, Charalambos, Stalikas, Anastasios, Kosmas, Epaminondas N., Anagnostakos, Theocharis, Palamidas, Anastasios F., Gennimata, Sofia-Antiopi, Karakontaki, Foteini, Koulouris, Nickolaos G.

“…Background. Cognitive deterioration may impair COPD patient’s ability to perform tasks like driving vehicles. We investigated: (a) whether subclinical…”
Get full text

Putative Mechanisms of Action of Endobronchial Coils by Palamidas, Anastasios F, Kemp, Samuel V, Shen, Mali, McNulty, Will, Zoumot, Zaid, Hopkinson, Nicholas S, Yang, Guang-Zhong, Shah, Pallav L

“…Bronchoscopic lung volume reduction methods are emerging as a viable alternative to lung volume reduction surgery (4-9). Recently, the RESET (Endobronchial…”
Get full text

Endobronchial Ultrasound Bronchoscopy to the Heart of the Matter by Palamidas, Anastasios F, Rosendahl, Ulrich, Shah, Pallav L

“…Endobronchial ultrasound has been one of the success stories of the last decade, and the utility of the procedure continues to expand. Originally, it was…”
Get more information

Impact of Hemodialysis on Dyspnea and Lung Function in End Stage Kidney Disease Patients by Vlahakos, Demetrios V., Koulouris, Nickolaos G., Palamidas, Anastasios F., Milic-Emili, Joseph, Koutsoukou, Antonia, Papantoniou, Ioannis, Gennimata, Sofia-Antiopi, Karakontaki, Foteini, Kaltsakas, Georgios

“…Background. Respiratory symptoms are usually underestimated in patients with chronic kidney disease undergoing maintenance hemodialysis. Therefore, we set out…”
Get full text

Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study by Christodolou, C, Pavlidis, N, Samantas, E, Fountzilas, G, Kouvatseas, G, Pagdatoglou, K, Palamidas, F, Nikolaidis, C, Angelidou, M, Kalofonos, H P, Kosmidis, P, Skarlos, D V

“…Prognostic factors among Greek patients with SCLC were evaluated. Data from 516 patients with SCLC treated by the Hellenic Cooperative Oncology Group were…”
Get more information

Multiple cervical and intrathoracic plexoid neurofibromas. Case report by Zisis, C, Dountsis, A, Tzamourani, E, Legaki, S, Rontogianni, D, Palamidas, F, Dahabreh, J

“…A 29-year-old male with known von Recklinghausen's disease is presented. The main symptom of the patient was paroxysmal episodes of pain and numbness in the…”
Get full text

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer by Agelaki, Sofia, Veslemes, Marinos, Syrigos, Kostas, Palamidas, Filippos, Polyzos, Aristidis, Papakotoulas, Pavlos, Kentepozidis, Nikolaos, Milaki, Georgia, Tzanakis, Nikolaos, Kouroussis, Charalambos, Vamvakas, Lambros, Georgoulias, Vassilis

“…Purpose: To evaluate the efficacy and toxicity of the combination of gemcitabine and docetaxel in pretreated patients with small-cell lung cancer (SCLC)…”
Get full text

Second-line treatment of non-small cell lung carcinomas with vinorelbine and ifosfamide: preliminary results of a phase II trial of the Greek Cooperative Group for Lung Cancer by Papadakis, E, Kourousis, Ch, Androulakis, N, Agelaki, S, Apostolopoulou, F, Palamidas, F, Rapti, A, Sarra, E, Tziani, V, Bania, E, Agelidou, A, Gianakakis, Th, Kandilis, K, Adravanis, A, Apostolaki, F, Georgoulias, V

Get full text

1078 Randomized comparison of Etoposide-Cisplatin vs Etoposide-Carboplatin and irradiation in small cell lung cancer (SCLC): Evaluation of long term survival by Samantas, E., Milonakis, M., Klouvas, G., Panoussaki, A., Agelidou, M., Palamidas, F., Boleli, E., Kosmas, E., Papadakis, E., Kiamouris, N., Vardoulakis, T., Kosmidis, P., Pavlidis, N., Foutzilas, G., Skarios, D.V.

“…Between 2/88 and 5/91, 143 patients (pts) with SCLC (82 extensive and 61 limited disease) were randomized to receive Cisplatin and Etoposide (PE) or…”
Get full text